Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis
Perifosine Increases PFS In Phase II Study
Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time
Carfilzomib Demonstrates Clinical Benefit Rate of 64%
Single-Letter Mutation Found Responsible For Waldenstrom’s
New Methods Uncover 1,800 RNAs Linked To Breast Cancer
Gene Expression Analyses Can Guide MDS Treatments
Analysis Reveals Patient Subset With Lower PFS in Phase III Trial
Interim Results Show Vaccine Lowers Breast Cancer Recurrence
CTCs Do Not Affect Survival, But Could Signal Metastases
Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects
Trials Approved by NCI CTEP For the Month of December
FDA Grants Orphan Designation To Photofrin for Mesothelioma
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial
